CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

被引:224
|
作者
Skillback, Tobias [1 ]
Farahmand, Bahman [2 ,3 ,4 ]
Bartlett, Jonathan W. [5 ]
Rosen, Christoffer [1 ]
Mattsson, Niklas [1 ,6 ]
Nagga, Katarina [7 ]
Kilander, Lena [8 ]
Religa, Dorota [2 ,3 ,4 ]
Wimo, Anders
Winblad, Bengt [2 ,3 ]
Rosengren, Lars [9 ]
Schott, Jonathan M. [10 ]
Blennow, Kaj [1 ]
Eriksdotter, Maria [2 ,3 ,4 ]
Zetterberg, Henrik [1 ,10 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Neurochem,Clin Nerochem Lab, Molndal, Sweden
[2] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Clin Geriatr, Stockholm, Sweden
[3] Karolinska Inst, KI Alzheimer Dis Res Ctr, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Geriatr Med, Stockholm, Sweden
[5] London Sch Hyg & Trop Med, Ctr Stat Methodol, London WC1, England
[6] Ctr Imaging Neurodegenerat Dis, Dept Vet Affairs Med Ctr, San Francisco, CA USA
[7] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden
[8] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala, Sweden
[9] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Neurol, Gothenburg, Sweden
[10] UCL Inst Neurol, London, England
基金
瑞典研究理事会;
关键词
AMYOTROPHIC-LATERAL-SCLEROSIS; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; PROTEIN-LEVELS; WHITE-MATTER; FRONTOTEMPORAL DEMENTIA; DIAGNOSTIC-CRITERIA; BIOMARKERS; MARKER; MANAGEMENT;
D O I
10.1212/WNL.0000000000001015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: We hypothesized that CSF neurofilament light (NFL) levels would be elevated in dementias with subcortical involvement, including vascular dementia (VaD), but less elevated in dementias primarily affecting gray matter structures, such as Alzheimer disease (AD), and that elevated CSF NFL would correlate with disease severity and shorter survival time irrespective of clinical diagnosis. Methods: We included 3,356 individuals with dementia who had CSF NFL analyzed in our laboratory between 2005 and 2012. Clinical diagnoses and Mini-Mental State Examination (MMSE) scores were obtained from the Swedish Dementia Registry, and in selected cases (n = 478), date of death from the Swedish Mortality Registry. Results: CSF NFL differed among clinical diagnoses, with the highest levels seen in frontotemporal dementia, VaD, and mixed AD and VaD. Early-onset AD (younger than 65 years) had the lowest levels. High CSF NFL correlated with low MMSE score and short survival time irrespective of diagnosis, and was also particularly evident in AD. Conclusions: CSF NFL differs among different neurodegenerative diseases and is especially high in dementias engaging subcortical brain regions, such as VaD and mixed AD and VaD, but also in frontotemporal dementia. The association of high CSF NFL levels with disease severity and short survival supports the notion that high CSF NFL levels indicate more aggressive disease processes.
引用
收藏
页码:1945 / 1953
页数:9
相关论文
共 50 条
  • [1] CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression
    Sun, Qionghua
    Zhao, Xue
    Li, Siyuan
    Yang, Fei
    Wang, Hongfen
    Cui, Fang
    Huang, Xusheng
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [2] Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
    Bacioglu, Mehtap
    Maia, Luis F.
    Preische, Oliver
    Schelle, Juliane
    Apel, Anja
    Kaeser, Stephan A.
    Schweighauser, Manuel
    Eninger, Timo
    Lambert, Marius
    Pilotto, Andrea
    Shimshek, Derya R.
    Neumann, Ulf
    Kahle, Philipp J.
    Staufenbiel, Matthias
    Neumann, Manuela
    Maetzler, Walter
    Kuhle, Jens
    Jucker, Mathias
    NEURON, 2016, 91 (01) : 56 - 66
  • [3] The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias
    Abu-Rumeileh, Samir
    Capellari, Sabina
    Stanzani-Maserati, Michelangelo
    Polischi, Barbara
    Martinelli, Paolo
    Caroppo, Paola
    Ladogana, Anna
    Parchi, Piero
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [4] The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias
    Samir Abu-Rumeileh
    Sabina Capellari
    Michelangelo Stanzani-Maserati
    Barbara Polischi
    Paolo Martinelli
    Paola Caroppo
    Anna Ladogana
    Piero Parchi
    Alzheimer's Research & Therapy, 10
  • [5] Neurofilament proteins in neurodegenerative diseases
    Liu, Q
    Xie, F
    Siedlak, SL
    Nunomura, A
    Honda, K
    Moreira, PI
    Zhua, X
    Smith, MA
    Perry, G
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (24) : 3057 - 3075
  • [6] Neurofilament proteins in neurodegenerative diseases
    Q. Liu
    F. Xie
    S. L. Siedlak
    A. Nunomura
    K. Honda
    P. I. Moreira
    X. Zhua
    M. A. Smith
    G. Perry
    Cellular and Molecular Life Sciences CMLS, 2004, 61 : 3057 - 3075
  • [7] CSF neurofilament light chain profiling and quantitation in neurological diseases
    Leckey, Claire A.
    Coulton, John B.
    Giovannucci, Tatiana A.
    He, Yingxin
    Aslanyan, Aram
    Laban, Rhiannon
    Heslegrave, Amanda
    Doykov, Ivan
    Ammoscato, Francesca
    Chataway, Jeremy
    De Angelis, Floriana
    Gnanapavan, Sharmilee
    Byrne, Lauren M.
    Schott, Jonathan M.
    Wild, Edward J.
    Barthelemy, Nicolas R.
    Zetterberg, Henrik
    Wray, Selina
    Bateman, Randall J.
    Mills, Kevin
    Paterson, Ross W.
    BRAIN COMMUNICATIONS, 2024, 6 (03)
  • [8] Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
    Gaiottino, Johanna
    Norgren, Niklas
    Dobson, Ruth
    Topping, Joanne
    Nissim, Ahuva
    Malaspina, Andrea
    Bestwick, Jonathan P.
    Monsch, Andreas U.
    Regeniter, Axel
    Lindberg, Raija L.
    Kappos, Ludwig
    Leppert, David
    Petzold, Axel
    Giovannoni, Gavin
    Kuhle, Jens
    PLOS ONE, 2013, 8 (09):
  • [9] Serum Neurofilament Light Predicts Severity and Prognosis in Patients with Ischemic Stroke
    Wang, Peng
    Fan, Jia
    Yuan, Ling
    Nan, Yi
    Nan, Shanji
    NEUROTOXICITY RESEARCH, 2020, 37 (04) : 987 - 995
  • [10] Serum Neurofilament Light Predicts Severity and Prognosis in Patients with Ischemic Stroke
    Peng Wang
    Jia Fan
    Ling Yuan
    Yi Nan
    Shanji Nan
    Neurotoxicity Research, 2020, 37 : 987 - 995